{
    "clinical_study": {
        "@rank": "75650", 
        "arm_group": [
            {
                "arm_group_label": "Cat-PAD Treatment 1", 
                "description": "Received Cat-PAD Treatment 1 in Study CP007 [NCT01620762]"
            }, 
            {
                "arm_group_label": "Cat-PAD Treatment 2", 
                "description": "Received Cat-PAD Treatment 2 in Study CP007 [NCT01620762]"
            }, 
            {
                "arm_group_label": "Cat-PAD Treatment 3", 
                "description": "Received Cat-PAD Treatment 3 in Study CP007 [NCT01620762]"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the continued effectiveness and safety of Cat-PAD\n      in cat allergic subjects for up to five years after the start of administration of\n      treatment. The study is an optional follow-up study to a phase III double-blind, placebo\n      controlled, Cat-PAD study; no further investigational product is administered."
        }, 
        "brief_title": "Phase III Cat-PAD Follow-on Study", 
        "completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Cat Allergy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  previously completed clinical study CP007 [NCT01620762]\n\n        Exclusion Criteria:\n\n          -  started allergen therapy since completing CP007\n\n          -  Institutionalised due to a legal or regulatory order"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "12 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects who have previously completed clinical study CP007 [NCT01620762]"
            }
        }, 
        "enrollment": {
            "#text": "1182", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02040844", 
            "org_study_id": "CP007 A"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cat-PAD Treatment 1", 
                "intervention_name": "Received Cat-PAD Treatment 1 in Study CP007 [NCT01620762]", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Cat-PAD Treatment 2", 
                "intervention_name": "Received Cat-PAD Treatment 2 in Study CP007 [NCT01620762]", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Cat-PAD Treatment 3", 
                "intervention_name": "Received Cat-PAD Treatment 3 in Study CP007 [NCT01620762]", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "May 6, 2014", 
        "number_of_groups": "3", 
        "official_title": "An Optional Prospective Follow-on Study to Evaluate the Continued Efficacy and Safety of Cat-PAD in Cat Allergic Subjects up to Five Years After the Administration of Treatment", 
        "overall_official": {
            "affiliation": "National Jewish Health", 
            "last_name": "Harold Nelson, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Canada: Health Canada", 
                "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
                "Czech Republic: State Institute for Drug Control", 
                "Germany: Paul-Ehrlich-Institut", 
                "Hungary: National Institute of Pharmacy", 
                "Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products", 
                "Slovakia: State Institute for Drug Control"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Combined Score of symptoms and allergy medication", 
            "safety_issue": "No", 
            "time_frame": "1, 2, 3 and 4 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02040844"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Symptom scores", 
                "safety_issue": "No", 
                "time_frame": "1, 2, 3 and 4 years"
            }, 
            {
                "measure": "Allergy Medication use", 
                "safety_issue": "No", 
                "time_frame": "1, 2, 3 and 4 years"
            }, 
            {
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "1, 2, 3 and 4 years"
            }, 
            {
                "measure": "Concomitant medication use", 
                "safety_issue": "Yes", 
                "time_frame": "up to 5 years"
            }, 
            {
                "measure": "Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "up to 5 years"
            }
        ], 
        "source": "Circassia Limited", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Circassia Limited", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}